TETON ATLAS
Live / Allowed — Notice of allowance issued (as of 17 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 22 May 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99197763
- Mark type
- Stylized text
- Filed
- 22 May 2025
- Published for opposition
- 20 Jan 2026
- Attorney of record
- Samantha C. Markley
Goods and services
- Class 001 — Chemicals: Assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for scientific research use, for diagnostic scientific use, and for clinical laboratory research use; clinical diagnostic reagents for laboratory use; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical diagnostic laboratory purposes
- Class 005 — Pharmaceuticals: Medical diagnostic reagents; clinical medical diagnostic reagents; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical medical diagnostic purposes; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for diagnostic medical use and for clinical medical use; diagnostic reagents for medical or veterinary purposes
- Class 009 — Scientific and electric apparatus: Computer systems, namely, computer hardware, downloadable and recorded computer software and associated downloadable data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; downloadable and recorded computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; clinical diagnostic instruments for scientific use, namely, nucleic acid sequencers, imaging devices and analyzers
- Class 010 — Medical apparatus: Clinical diagnostic instruments for medical use, namely, nucleic acid sequencers, imaging devices for biomolecules and analyzers in the nature of flow-based analyzers providing cell and particle analysis, detection, or counting
- Class 042 — Scientific and technological services: Providing reagent sample diagnostic testing services for others for scientific research purposes and scientific research related thereto; clinical diagnostic services for scientific research purposes, namely, preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids from human beings; providing online non-downloadable computer software for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; providing online non-downloadable computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes
Owner
- Element Biosciences, Inc., San Diego, CA, US
- Element Biosciences, Inc., San Diego, CA, US
Prosecution history
- 17 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Jan 2026 — PUBLISHED FOR OPPOSITION
- 14 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 15 Oct 2025 — NON-FINAL ACTION E-MAILED
- 15 Oct 2025 — NON-FINAL ACTION WRITTEN
- 06 Oct 2025 — ASSIGNED TO EXAMINER
- 30 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 22 May 2025 — APPLICATION FILING RECEIPT MAILED
- 22 May 2025 — NEW APPLICATION ENTERED